ExtriCARE USA Launches Innovative Medical Device Company, Offering Negative Pressure Wound Therapy Solutions

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

October 20, 2020

ExtriCARE USA  a national medical device company specializing in the distribution of negative pressure wound therapy (NPWT), officially announces its company launch and new user-centric website.

ExtriCARE USA, led by President Peter Mason, who has over eight years of industry experience, is fostering the future of healthcare with wound care technologies that improve patient outcomes, help clinicians with efficiency and reduce overall costs. NPWT is a modern resource still in its infancy stage. With a tailored and hands-on approach, the ExtriCARE USA team is working diligently to amplify its potential.

“I have a driving passion to develop reliable NPWT products for our network of dealers, which in turn helps patients live a better-quality life,” said Mason. “I am excited to continue building strong partnerships with dealers nationwide, allowing us to support patients and clinicians alike while reaching new heights of growth together.”

To coincide with the company’s launch, ExtriCARE USA has built a new website designed with the user in mind. The website has in-depth information on the ExtriCARE product line, the leadership team and press page with the company’s latest insights.

“With over a decade of experience in wound care, I am fortunate and proud to be a part of such a dynamic and forward-thinking team,” said Gary Schear, Vice President of Sales. “Our patient-first mentality is a driving force, and we hope to continue being a trustworthy lifeline for our providers so that they can be the lifeline for their patients.”

The ExtriCARE USA leadership team, comprised of Peter Mason, Gary Schear and Tony Cheung (Director of Operations), is committed to the future of NPWT. In partnership with Alleva Medical, the company is introducing a new product line that will transform traditional NPWT. The products are designed to be versatile, featuring state-of-the-art technology and optimized software. ExtriCARE USA and Alleva Medical will bring these portable, powerful and adaptive solutions to the market soon.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles